Clinical trial
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status…
NCT00362141 · Medical Center Haaglanden, Other · Unknown status
Key facts
| NCT number | NCT00362141 |
|---|---|
| Title | Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus |
| Official title | Safety and Tolerability of Add-on Levetiracetam in Status Epilepticus |
| Lead sponsor | Medical Center Haaglanden, Other |
| Collaborators | UCB Pharma Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Status Epilepticus |
| Intervention type | Drug |
| Interventions | levetiracetam (add-on) |
| Enrollment | 12 |
| Start date | Oct 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Aug 9, 2006 |
| Last update posted | Apr 2, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: